UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Plasma eNOS Concentration in Healthy Pregnancy and in Hypertensive Disorders of Pregnancy: Evidence of Reduced Concentrations in Pre-Eclampsia from Two Independent Studies

Diseases, 2023-11, Vol.11 (4), p.155

2023

Volltextzugriff (PDF)

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

Molecular human reproduction, 2009-02, Vol.15 (2), p.115-120

2009

Volltextzugriff (PDF)

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Hypertension (Dallas, Tex. 1979), 2008-08, Vol.52 (2), p.402-407

2008

Volltextzugriff (PDF)

Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers

European journal of clinical pharmacology, 2011-04, Vol.67 (4), p.365-370

2011

Volltextzugriff (PDF)

Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia

Molecular human reproduction, 2010-07, Vol.16 (7), p.506-510

2010

Volltextzugriff (PDF)

Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy

Experimental and molecular pathology, 2012-04, Vol.92 (2), p.217-221

2012

Volltextzugriff (PDF)

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre‐eclampsia

Journal of cellular and molecular medicine, 2013-10, Vol.17 (10), p.1300-1307

2013

Volltextzugriff (PDF)

Effects of Matrix Metalloproteinase (MMP)-2 Polymorphisms on Responsiveness to Antihypertensive Therapy of Women with Hypertensive Disorders of Pregnancy

Basic & clinical pharmacology & toxicology, 2012-10, Vol.111 (4), p.262-267

2012

Volltextzugriff (PDF)

Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine

European journal of pharmacology, 2010-02, Vol.627 (1), p.216-222

2010

Volltextzugriff (PDF)

Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions

Clinical chemistry and laboratory medicine, 2009-07, Vol.47 (7), p.888-891

2009

Volltextzugriff (PDF)

Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity

Clinical biochemistry, 2011-08, Vol.44 (12), p.1012-1014

2011

Volltextzugriff (PDF)

Matrix metalloproteinases as drug targets in preeclampsia

Current drug targets, 2013-03, Vol.14 (3), p.325

2013

Volltextzugriff (PDF)

Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension

Clinical biochemistry, 2008-07, Vol.41 (10), p.875-880

2008

Volltextzugriff (PDF)

Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies

Clinica chimica acta, 2013-08, Vol.423, p.112-115

2013

Volltextzugriff (PDF)

Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension

Clinica chimica acta, 2010-06, Vol.411 (11-12), p.874-877

2010

Volltextzugriff (PDF)

Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia

Free radical biology & medicine, 2010-08, Vol.49 (3), p.493-500

2010

Volltextzugriff (PDF)

Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant

Pregnancy hypertension, 2015-04, Vol.5 (2), p.205-208

2015

Volltextzugriff (PDF)

Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia

Clinica chimica acta, 2010-10, Vol.411 (19), p.1457-1460

2010

Volltextzugriff (PDF)

Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension

Naunyn-Schmiedeberg's archives of pharmacology, 2012-05, Vol.385 (5), p.509-517

2012

Volltextzugriff (PDF)

NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia

Pregnancy hypertension, 2019-10, Vol.18, p.137-140

2019

Volltextzugriff (PDF)

Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy

Hypertension research, 2015-05, Vol.38 (5), p.361-366

2015

Volltextzugriff (PDF)

Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy

Blood pressure, 2016-08, Vol.25 (4), p.241-243

2016

Volltextzugriff (PDF)

Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms

Archives of gynecology and obstetrics, 2015-04, Vol.291 (4), p.799-803

2015

Volltextzugriff (PDF)

eNOS tag SNP haplotypes in hypertensive disorders of pregnancy

DNA and cell biology, 2012-12, Vol.31 (12), p.1665

2012

Volltextzugriff (PDF)

Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia

Hypertension in pregnancy, 2014-02, Vol.33 (1), p.72-80

2014

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(81)

Sprache

Englisch
(81)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Plasma eNOS Concentration in Healthy Pregnancy and in Hypertensive Disorders of Pregnancy: Evidence of Reduced Concentrations in Pre-Eclampsia from Two Independent Studies

Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers

Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia

Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy

Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre‐eclampsia

Effects of Matrix Metalloproteinase (MMP)-2 Polymorphisms on Responsiveness to Antihypertensive Therapy of Women with Hypertensive Disorders of Pregnancy

Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine

Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions

Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity

Matrix metalloproteinases as drug targets in preeclampsia

Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension

Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies

Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension

Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia

Positive correlations between circulating adiponectin and MMP2 in preeclampsia pregnant

Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia

Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension

NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia

Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy

Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy

Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphisms

eNOS tag SNP haplotypes in hypertensive disorders of pregnancy

Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia

Suchergebnisse filtern